Criteria Bio Ventures leads a €3 million investment in Adaptam Therapeutics

by CriteriaCaixa

This financing round will enable Adaptam to continue advancing its programs and initiate the preclinical phase across multiple oncology indications. As part of the round, Salvatore Cappadona, PhD, and...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

SICC Innvierte, a vehicle managed by CDT...

by CDTI Innovación

With a target size of €250 million, the fund aims to complete betwee...

Photos Stream